SCHEMBL2449912

SCHEMBL2449912

O=C(CNc1ccccc1)N1CCc2nc3ccccc3c(C(=O)N3CCOCC3)c2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ MAPT P10636 1/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ POLB P06746 2/20 0.43
▸ RECQL P46063 2/20 0.43
▸ MCL1 Q07820 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ BCHE P06276 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ PIK3CD O00329 2/20 0.40
▸ PIK3R2 O00459 2/20 0.40
▸ PIK3CA P42336 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2323530 0.92 MAPT (0.42) ALDH1A1KDM4EHTTMAPTMEN1
SCHEMBL2319203 0.89 PIK3CD (0.43) ALDH1A1MAPTMEN1KMT2APOLB
SCHEMBL2317218 0.89 MAPT (0.45) ALDH1A1KDM4EHTTMAPTMEN1
SCHEMBL2322437 0.84 FKBP1A (0.55) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL2321559 0.81 MAPT (0.44) ALDH1A1KDM4EHTTMAPTMEN1
SCHEMBL26454872 0.79 MAPT (0.61) ALDH1A1KDM4EHTTMAPTMEN1
SCHEMBL2450519 0.79 SMN1; SMN2 (0.43) ALDH1A1KDM4EHTTMAPTMEN1
SCHEMBL2321096 0.79 FKBP1A (0.43) ALDH1A1KDM4EMEN1KMT2ATDP1
SCHEMBL2320640 0.79 ALDH1A1 (0.60) ALDH1A1KDM4EHTTMAPTMEN1
SCHEMBL2451622 0.78 FKBP1A (0.45) ALDH1A1MAPTLMNATSHRPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US claimed
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US disclosed
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN ENPP2, TPX2, TPD52L2 ALDH1A1 4584/4885KDM4E 1953/4885HTT 653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback